Rocuronium Bromide Injection
Product Images NDC 43066-007

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 43066-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rocuronium Structural Formula (Image 01)

Chemical structure of rocuronium bromide, showing its steroidal framework with various functional groups including an acetate ester, quaternary ammonium, hydroxyl group, and bromide ion.*

FDA Label Image

Figure 1 (Rocuronium Function of Dose)

A box plot chart depicting time in minutes on the vertical axis versus dose in mg/kg on the horizontal axis for different age groups: 18-64 years, 65 years and older, and 1-12 years. The chart shows distribution and variability of data points for each dose and age group combination.*

FDA Label Image

Figure 2 (Rocuronium Function of Dose)

A box plot chart comparing the duration in minutes of Rocuronium Bromide injection across different age groups (18-64 years, 65 years and older, 3 months to 1 year, 1 to 12 years) and dosages (0.45, 0.9, 1, 2, 3, 8 mg/kg). The y-axis represents time in minutes, and the x-axis shows dosage and age group categories.*

FDA Label Image

Figure 3 (Rocuronium Clinical Durations)

A line graph showing the relationship between dose number (x-axis) and time in minutes (y-axis) for Rocuronium Bromide intravenous injection at two different doses, 0.1 mg/kg and 0.15 mg/kg. The graph indicates different sample sizes for each dose group (N=29 for 0.1 mg/kg, N=13 for 0.15 mg/kg).*

FDA Label Image

Rocuronium Representative Container Label 43066-007-10 (Image 05)

Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) in a 5 mL multiple dose vial. The label includes warnings about the drug being a paralyzing agent for IV use only. Distributed by Baxter Healthcare Corporation. It displays the NDC 43066-007-10 and indicates it is Rx only.*

FDA Label Image

Rocuronium Representative Carton Label 43066-007-10 1 Of 2 (Image 06)

The image shows the packaging label for Rocuronium Bromide injection, 50 mg/5 mL (10 mg/mL) in a 10 x 5 mL multiple dose vial. The label is manufactured by Baxter Healthcare Corporation and includes a warning to 'Prayzing Agent'. The label is oriented upside down and features barcodes and a colored stripe.*

FDA Label Image

Rocuronium Representative Carton Label 43066-007-10 2 Of 2 (Image 07)

Packaging label for Rocuronium Bromide Injection, 100 mg/10 mL multiple dose vials, manufactured by Baxter Healthcare Corporation. The label includes warnings, dosage information, and storage instructions. The label states a 10 x 5 mL multiple dose vial configuration.*

FDA Label Image

Rocuronium Representative Container Label 43066-013-10 (Image 08)

Label for Rocuronium Bromide injection, 50 mg/5 mL (10 mg/mL) in multiple dose vials. The label includes a warning that it is a paralyzing agent and specifies use for intravenous administration only. Distributed by Baxter Healthcare Corporation.*

FDA Label Image

Rocuronium Representative Carton Label 43066-013-10 1 Of 2 (Image 09)

Rocuronium Bromide injection 50 mg/5 mL (10 mg/mL) in a multiple-dose vial package. The label includes a note that the container closure is not made with natural rubber latex. The product is labeled by Baxter Healthcare Corporation and the package contains 10 vials of 5 mL each.*

FDA Label Image

Rocuronium Representative Carton Label 43066-013-10 2 Of 2 (Image 10)

Label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) intravenous injection. The label states it is a sterile, nonpyrogenic paralyzing agent for IV use only, with warnings about respiratory arrest risk. It is a 10 mL multiple dose vial distributed by Baxter Healthcare Corporation. The label includes instructions for storage, use, and disposal, along with National Drug Code (NDC) 43066-013-10 and barcode.*

FDA Label Image

Image 11

Packaging label for Rocuronium Bromide Injection 100 mg/10 mL by Baxter Healthcare Corporation. The label indicates the product is for intravenous use and includes batch information and barcode. The package is a carton designed to hold 10 vials of 10 mL multiple dose each.*

FDA Label Image

Image 12

Packaging label for Rocuronium Bromide Injection, 10 x 10 mL multiple dose vials, with NDC 43065-013-10. The label includes storage instructions, dosage form, strength, and expiration details. The product is labeled by Baxter Healthcare Corporation for intravenous use.*

FDA Label Image

Image 13

Label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) by Baxter Healthcare Corporation. The label indicates the product is for intravenous use only, includes a warning that it is a paralysing agent, and specifies package of 10 x 10 mL multiple dose vials. Distributed by Baxter Healthcare Corporation, product of Germany.*

FDA Label Image

Image 14

Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) label for a carton containing 10 x 10 mL multiple dose vials. The label indicates the product is manufactured by Baxter Healthcare Corporation and notes the container closure is not made with natural rubber latex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.